Evidence map›Paper›PMID 33410863›Full record

ArticleThe Journal of general physiology2021

Proteomic and functional mapping of cardiac NaV1.5 channel phosphorylation sites.

Maxime Lorenzini, Sophie Burel, Adrien Lesage, Emily Wagner, Camille Charrière, Pierre-Marie Chevillard, Bérangère Evrard, Dan Maloney, Kiersten M Ruff, Rohit V Pappu and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of general physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Functional cross-talk between phosphorylation and disease-causing mutations in the cardiac sodium channel NaProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 4 countries.

Maxime LorenziniUniversité de Nantes, Centre national de la recherche scientifique, Institut National de la Santé et de la Recherche Médicale, l'Institut du thorax, Nantes, France.
Sophie BurelUniversité de Nantes, Centre national de la recherche scientifique, Institut National de la Santé et de la Recherche Médicale, l'Institut du thorax, Nantes, France.
Adrien LesageUniversité de Nantes, Centre national de la recherche scientifique, Institut National de la Santé et de la Recherche Médicale, l'Institut du thorax, Nantes, France.
Emily WagnerDepartment of Biomedical Engineering, Washington University in Saint Louis, St. Louis, MO.
Camille CharrièreUniversité de Nantes, Centre national de la recherche scientifique, Institut National de la Santé et de la Recherche Médicale, l'Institut du thorax, Nantes, France.
Pierre-Marie ChevillardUniversité de Nantes, Centre national de la recherche scientifique, Institut National de la Santé et de la Recherche Médicale, l'Institut du thorax, Nantes, France.
Bérangère EvrardUniversité de Nantes, Centre national de la recherche scientifique, Institut National de la Santé et de la Recherche Médicale, l'Institut du thorax, Nantes, France.
Dan MaloneyBioinformatics Solutions Inc., Waterloo, Ontario, Canada.
Kiersten M RuffDepartment of Biomedical Engineering, Washington University in Saint Louis, St. Louis, MO.
Rohit V PappuDepartment of Biomedical Engineering, Washington University in Saint Louis, St. Louis, MO.
Stefan WagnerDepartment of Internal Medicine II, University Heart Center, University Hospital Regensburg, Regensburg, Germany.
Jeanne M NerbonneDepartment of Developmental Biology, Washington University Medical School, St. Louis, MO.
Jonathan R SilvaDepartment of Biomedical Engineering, Washington University in Saint Louis, St. Louis, MO.
R Reid TownsendDepartment of Medicine, Washington University Medical School, St. Louis, MO.
Lars S MaierDepartment of Internal Medicine II, University Heart Center, University Hospital Regensburg, Regensburg, Germany.
Céline MarionneauUniversité de Nantes, Centre national de la recherche scientifique, Institut National de la Santé et de la Recherche Médicale, l'Institut du thorax, Nantes, France.
Inserm · FRWashington University in St. Louis · USUniversity Hospital Regensburg · DEBioinformatics Solutions (Canada) · CA

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI AIMEE S JAMES · 2001 to 2026
$128.0M
WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
TrainingP41GM103422 · NIGMS · WASHINGTON UNIVERSITY · PI YARASHESKI, KEVIN E · 2012 to 2019
$12.0M
ION CHANNEL REGULATION AND MODULATION IN CARDIAC MUSCLER01HL034161 · NHLBI · WASHINGTON UNIVERSITY · PI NERBONNE, JEANNE M. · 1986 to 2015
$4.6M
ROLE OF CHAIN LENGTH AND SEQUENCE CONTEXTS ON POLYGLUTAMINE OLIGOMERIZATIONR01NS056114 · NINDS · WASHINGTON UNIVERSITY · PI PAPPU, ROHIT V · 2007 to 2020
$4.4M
Personalizing Class I anti-Arrhythmic Drug TherapyR01HL148803 · NHLBI · WASHINGTON UNIVERSITY · PI SILVA, JONATHAN R · 2020 to 2024
$3.2M
Molecular Determinants of Regional Differences in Human Ventricular Repolarization and RemodelingR01HL142520 · NHLBI · WASHINGTON UNIVERSITY · PI NERBONNE, JEANNE M. · 2019 to 2022
$1.6M
NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1 TR002345NCI NIH HHS P30 CA091842NHLBI NIH HHS R01 HL034161NHLBI NIH HHS R01 HL142520NHLBI NIH HHS R01 HL148803NIGMS NIH HHS P41 GM103422NINDS NIH HHS R01 NS056114
6 · The paper itself

Abstract

Phosphorylation of the voltage-gated Na+ (NaV) channel NaV1.5 regulates cardiac excitability, yet the phosphorylation sites regulating its function and the underlying mechanisms remain largely unknown. Using a systematic, quantitative phosphoproteomic approach, we analyzed NaV1.5 channel complexes purified from nonfailing and failing mouse left ventricles, and we identified 42 phosphorylation sites on NaV1.5. Most sites are clustered, and three of these clusters are highly phosphorylated. Analyses of phosphosilent and phosphomimetic NaV1.5 mutants revealed the roles of three phosphosites in regulating NaV1.5 channel expression and gating. The phosphorylated serines S664 and S667 regulate the voltage dependence of channel activation in a cumulative manner, whereas the nearby S671, the phosphorylation of which is increased in failing hearts, regulates cell surface NaV1.5 expression and peak Na+ current. No additional roles could be assigned to the other clusters of phosphosites. Taken together, our results demonstrate that ventricular NaV1.5 is highly phosphorylated and that the phosphorylation-dependent regulation of NaV1.5 channels is highly complex, site specific, and dynamic.

Indexed as

Heart VentriclesProteomicsAnimalsMiceNAV1.5 Voltage-Gated Sodium ChannelPhosphorylationSerineSodiumNAV1.5 Voltage-Gated Sodium ChannelSerineSodium

Identifiers

PMID33410863
PMCPMC7797897
OpenAlexW3120693979

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.